- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Ziccum AB: Ziccum publishes prospectus due to upcoming rights issue | 45 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH... ► Artikel lesen | |
| Mi | XFRA CAPITAL ADJUSTMENT INFORMATION - 20.11.2024 | 164 | Xetra Newsboard | Das Instrument M7ES IE000K6PPGX7 HANETF-SPR.EN.TRA.MT.EOAC ETF wird cum Kapitalmassnahme gehandelt am 20.11.2024 und ex Kapitalmassnahme am 21.11.2024 The instrument M7ES IE000K6PPGX7 HANETF-SPR.EN.TRA.MT.EOAC... ► Artikel lesen | |
| 29.10. | Ziccum AB: Ziccum AB (publ) Interim report Q3 2024 | 81 | GlobeNewswire (Europe) | INTERIM REPORT Q3, 1 JULY - 30 SEPTEMBER 2024
Significant events after Q3 2024Ziccum intends to resolve on a rights issue of approximately SEK 30 million and raises a bridge loanOn October 10, The Board... ► Artikel lesen | |
| 10.10. | Ziccum AB: Ziccum intends to resolve on a rights issue of approximately SEK 30 million and raises a bridge loan | 77 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH... ► Artikel lesen | |
| 30.08. | Ziccum AB: Ziccum AB (publ) Interim report Q2 2024 | 99 | GlobeNewswire (Europe) | INTERIM REPORT Q2, 1 JANUARY - 30 JUNE 2024
Significant events during Q2 2024Ziccum strengthens and streamlines business and finance functionsOn April 3, the company announced that it is reorganizing... ► Artikel lesen | |
| 29.04. | Ziccum AB: Ziccum AB (publ) Interim report Q1 2024 | 48 | GlobeNewswire (Europe) | INTERIM REPORT Q1, 1 JANUARY - 31 MARCH 2024
Significant events during the QuarterSuccessful outcomes of LaminarPace Feasibility study with Biotech partnerOn January 10, the company announced that,... ► Artikel lesen | |
| ZICCUM Aktie jetzt für 0€ handeln | |||||
| 06.03. | Nasdaq Stockholm AB: New equity right for trading, Ziccum AB TO5 (114/24) | 245 | GlobeNewswire | At the request of Ziccum AB, Ziccum AB equity rights will be traded on First
North Growth Market as from March 7, 2024.
Security name: Ziccum AB TO5
-----------------------------
Short name: ZICC... ► Artikel lesen | |
| 29.02. | Nasdaq Stockholm AB: Delising of paid subscription units of Ziccum AB from First North Growth Market (100/24) | 334 | GlobeNewswire | Last day of trading in paid subscription units (BTA) of Ziccum AB
Trading in Ziccum AB paid subscription units is to cease. The last trading day
is March 1, 2024.
Short name: ZICC BTU
---------------------------
ISIN... ► Artikel lesen | |
| 30.01. | Nasdaq Stockholm AB: Listing of unit rights and subscription units of Ziccum AB (44/24) | 345 | GlobeNewswire | With effect from January 31, 2024, the unit rights in Ziccum AB will be traded
on First North Growth Market. Trading will continue up until and including
February 09, 2024.
Instrument: Unit rights... ► Artikel lesen | |
| 26.01. | Ziccum AB: Year-End report Q4 2023 | 492 | GlobeNewswire (Europe) | YEAR-END REPORT Q4 2023: 1 JANUARY - 31 DECEMBER 2023
Significant events during the QuarterCollaboration agreement with University of CopenhagenOn December 4th, the company announced that it had signed... ► Artikel lesen | |
| 26.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 26.01.2024 | 673 | Xetra Newsboard | Das Instrument 4DX GB00BJTCG679 DX (GROUP) PLC LS -,01 EQUITY wird cum Kapitalmassnahme gehandelt am 26.01.2024 und ex Kapitalmassnahme am 29.01.2024 The instrument 4DX GB00BJTCG679 DX (GROUP) PLC LS... ► Artikel lesen | |
| 21.12.23 | Ziccum AB: CEO's Seasons Greetings 2023: A pivotal year of significant results | 191 | GlobeNewswire (Europe) | At the end of an exciting and eventful year, Ziccum CEO Ann Gidner summarizes the milestones reached, the robust Ziccum Strategic roadmap underpinning them and looks forward to a busy and dynamic 2024.
Dear... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 32,950 | +2,30 % | WARBURG RESEARCH stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Das Analysehaus Warburg Research hat das Kursziel für Fresenius von 44 auf 42 Euro gesenkt, aber die Einstufung auf "Buy" belassen. "Nächster Schritt: Revitalisierung",... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 49,050 | -1,31 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers nach einer Investorenveranstaltung mit einem Kursziel von 65,90 Euro auf "Overweight" belassen. Die Themen... ► Artikel lesen | |
| THERMO FISHER | 492,35 | +1,16 % | End Market Growth, New Acquisitions Drive Thermo Fisher's Shares | ||
| EUROFINS SCIENTIFIC | 46,680 | +1,35 % | Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 October 2024 | Regulatory News:
Eurofins Scientific SE (Paris:ERF):
ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal... ► Artikel lesen | |
| SYNLAB | 11,460 | 0,00 % | Cinven secures Italian nod to sell minority stake in Synlab to Labcorp | ||
| DAVITA | 153,95 | +0,52 % | DaVita-Aktie leicht im Minus (149,1616 €) | An der US-amerikanischen Börse notiert das Wertpapier von DaVita derzeit etwas leichter. Zuletzt zahlten Investoren für das Wertpapier 157,98 US-Dollar. Für der Anteilsschein von DaVita steht gegenwärtig... ► Artikel lesen | |
| DENTSPLY SIRONA | 17,770 | +1,08 % | Dentsply Sirona-Direktor Gregory Lucier kauft Aktien im Wert von 110.128 US-Dollar | ||
| SMITH & NEPHEW | 11,865 | +0,34 % | Investors urge Smith+Nephew to consider break-up over orthopedics performance | ||
| SONIC HEALTHCARE | 16,902 | -0,83 % | SONIC HEALTHCARE LIMITED: Notification of cessation of securities - SHL | ||
| DIASORIN | 103,20 | -2,04 % | Milan: Strong day for DiaSorin | ||
| PATTERSON COMPANIES | 19,900 | +4,74 % | Patterson Companies Stock Up Following Latest Partnership Extension | ||
| FULGENT GENETICS | 16,000 | 0,00 % | Fulgent Reports Third Quarter 2024 Financial Results | EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic... ► Artikel lesen | |
| IMPLANTICA | 3,315 | -1,78 % | Implantica publishes Interim Report January - September 2024 (Q3) |
VADUZ, Liechtenstein, Nov. 15, 2024 /PRNewswire/ -- RefluxStop achieves crucial FDA milestone and leaps forward with strong momentum in both the US and Europe
Significant events in the... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 4,800 | -17,95 % | Perspective Therapeutics, Inc.: Perspective Therapeutics to Discuss Data on [212Pb]VMT-a-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024 | ||
| OMNICELL | 39,800 | 0,00 % | Omnicell prices $150M debt offering via issuance of convertible senior notes |
ZICCUM AB gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,086 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ZICCUM AB finden Sie auf Wallstreet Online.
